Latest Research in Inflammatory Biomarkers in Disease Prognosis
104 research papers · 0.0 average citations · 2026 median publication year
Top Research Topics in Inflammatory Biomarkers in Disease Prognosis
- Renal cell carcinoma treatment — 16 papers
- Inflammatory Biomarkers in Disease Prognosis — 12 papers
- Cancer Immunotherapy and Biomarkers — 7 papers
- Genetic factors in colorectal cancer — 6 papers
- Bladder and Urothelial Cancer Treatments — 6 papers
- Colorectal Cancer Treatments and Studies — 5 papers
- Gastric Cancer Management and Outcomes — 4 papers
- Pancreatic and Hepatic Oncology Research — 3 papers
- Cholangiocarcinoma and Gallbladder Cancer Studies — 3 papers
- Renal and related cancers — 3 papers
Highest-Cited Papers
- Benchmarking UK Lynch syndrome colonoscopy surveillance: quality metrics and diagnostic yield from the National Endoscopy Database (1 citations)
- A reproducibility benchmark of transcriptomic prognostic signatures in pancreatic ductal adenocarcinoma: protocol and feasibility assessment
- A reproducibility benchmark of transcriptomic prognostic signatures in pancreatic ductal adenocarcinoma: protocol and feasibility assessment
- Significance of next-generation sequencing in the era of targeted therapy for biliary tract cancer: an analysis at a single institution
- Communicating the uncertainty of individual risk from clinical prediction tools with the PGower similarity measure
- Effects of Adjunctive Electroacupuncture on Chemotherapy-Induced Nausea and Vomiting and Quality of Life in Subjects With Gynecologic Malignancies: A Retrospective Cohort Study
- Limitations of PIV Biomarker Analysis Related to Chemoradiotherapy and Unadjusted Confounders
- Adult Mixed Epithelial and Stromal Tumor of the Kidney Harbors Recurrent Whole Chromosome 12 Gain
- Integrated genomic and transcriptomic profiling across the clinical spectrum of Lynch syndrome-associated endometrial disease
- Can Chemoradiotherapy Expand Immune Checkpoint Blockade Responsiveness in Mismatch Repair‐Proficient Rectal Cancer?
- FOLFOX Plus Bevacizumab Rechallenge Versus Regorafenib as Third-Line Treatment in Metastatic Colorectal Cancer: The Role of the Oxaliplatin-Free Interval
- Fumarate Hydratase-Deficient Uterine Leiomyomas: Germline Genetic Findings and Clinical Follow-Up in a Single-Center Cohort
- Associations of Multiple Serum Tumor Markers with Radiological Response and Overall Survival in Patients with Advanced Gastric Cancer Receiving First-Line Palliative Systemic Therapy
- Real-world treatment patterns and outcomes in metastatic clear cell renal cell carcinoma following immune checkpoint inhibitor progression (2018-2023)
- Artificial intelligence in gastric cancer research: a bibliometric and visualized analysis from 1993 to 2026
- Composite clinical scores in real-world extensive-stage small-cell lung cancer patients treated with chemo-immunotherapy
- Case Report: Marked elevation of serum procalcitonin before radiographic confirmation of recurrence in stage IVB pulmonary large cell neuroendocrine carcinoma
- A prognostic model integrating systemic inflammation and clinical features for overall survival in lung cancer: development, internal validation, and external evaluation
- The use of blood test trends in cancer detection: a scoping review
- Age-related variation in heart rate variability across receptor-defined breast cancer groups, with distinct patterns in triple-negative disease: a cross-sectional study